[{"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-001", "question": "A 48-year-old woman with a history of systemic lupus erythematosus (SLE) on hydroxychloroquine and low-dose prednisone presents with 3 weeks of progressive dyspnea on exertion and dry cough. High-resolution CT shows diffuse ground-glass opacities with superimposed fine reticulation and subpleural sparing. Bronchoalveolar lavage reveals lymphocytic predominance (65%) with CD4:CD8 ratio of 0.8. Pulmonary function tests show a restrictive pattern with severely reduced DLCO (38% predicted). Which of the following is the most appropriate next step in management?", "options": ["Initiate high-dose intravenous methylprednisolone followed by oral prednisone 1 mg/kg/day", "Add mycophenolate mofetil to current immunosuppression", "Discontinue hydroxychloroquine and observe for 4 weeks", "Perform surgical lung biopsy to confirm usual interstitial pneumonia pattern", "Start rituximab therapy without additional testing"], "answer": "B", "answer_index": 1, "explanation": "The presentation is classic for lymphocytic interstitial pneumonia (LIP) associated with SLE, characterized by ground-glass opacities with reticulation, lymphocytic BAL, and low CD4:CD8 ratio. LIP in connective tissue disease typically requires more aggressive immunosuppression beyond steroids alone. Mycophenolate mofetil is the preferred steroid-sparing agent for SLE-associated interstitial lung disease with this pattern. High-dose steroids alone (A) are insufficient for progressive LIP. Hydroxychloroquine cessation (C) is unlikely to reverse established ILD. Surgical biopsy (D) is unnecessary with characteristic HRCT and BAL findings. Rituximab (E) is reserved for refractory cases after conventional immunosuppression fails.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: SLE patient; 3 weeks of progressive dyspnea and dry cough; HRCT with diffuse ground-glass opacities, fine reticulation, subpleural sparing; BAL with lymphocytic predominance and low CD4:CD8 ratio; restrictive PFTs with markedly reduced DLCO. These findings are consistent with a connective-tissue–disease–associated interstitial lung disease, compatible with LIP/nonspecific interstitial pneumonia spectrum. The disease is progressive despite baseline low-dose prednisone and hydroxychloroquine.\\nOption B (add mycophenolate mofetil) is appropriate escalation with a commonly used first-line steroid-sparing agent for SLE-associated ILD; it addresses progressive disease and aligns with standard practice. A (pulse/high-dose steroids) could be used, but the stem emphasizes chronic progressive ILD rather than acute fulminant pneumonitis; guidelines and practice generally favor adding a steroid-sparing immunosuppressant. C (stop hydroxychloroquine) is not expected to reverse established ILD. D (surgical biopsy) is not required when CT/BAL are characteristic and would delay therapy. E (rituximab) is typically reserved for refractory or severe cases after mycophenolate/azathioprine or cyclophosphamide.\\nMain medical accuracy issues: minor—LIP vs NSIP labeling is somewhat overspecified, but does not affect the management choice.\\nMinimal fix: Clarify in stem that disease is worsening despite adequate trial of low-to-moderate steroids to better justify moving directly to mycophenolate rather than just high-dose steroids alone.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: SLE patient; 3 weeks of progressive dyspnea and dry cough; HRCT with diffuse ground-glass opacities, fine reticulation, subpleural sparing; BAL with lymphocytic predominance and low CD4:CD8 ratio; restrictive PFTs with markedly reduced DLCO. These findings are consistent with a connective-tissue–disease–associated interstitial lung disease, compatible with LIP/nonspecific interstitial pneumonia spectrum. The disease is progressive despite baseline low-dose prednisone and hydroxychloroquine.\nOption B (add mycophenolate mofetil) is appropriate escalation with a commonly used first-line steroid-sparing agent for SLE-associated ILD; it addresses progressive disease and aligns with standard practice. A (pulse/high-dose steroids) could be used, but the stem emphasizes chronic progressive ILD rather than acute fulminant pneumonitis; guidelines and practice generally favor adding a steroid-sparing immunosuppressant. C (stop hydroxychloroquine) is not expected to reverse established ILD. D (surgical biopsy) is not required when CT/BAL are characteristic and would delay therapy. E (rituximab) is typically reserved for refractory or severe cases after mycophenolate/azathioprine or cyclophosphamide.\nMain medical accuracy issues: minor—LIP vs NSIP labeling is somewhat overspecified, but does not affect the management choice.\nMinimal fix: Clarify in stem that disease is worsening despite adequate trial of low-to-moderate steroids to better justify moving directly to mycophenolate rather than just high-dose steroids alone.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-002", "question": "A 62-year-old man with metastatic renal cell carcinoma on nivolumab and ipilimumab presents with acute-onset diplopia, ptosis, and dysphagia 6 weeks after initiation. Neurological exam reveals bilateral asymmetric ophthalmoparesis, fatigable ptosis, proximal muscle weakness, and normal pupillary responses. Repetitive nerve stimulation shows 25% decrement at 3Hz. Which of the following is the most specific diagnostic test to confirm the underlying pathophysiology?", "options": ["Anti-acetylcholine receptor antibody titer", "Anti-MuSK antibody testing", "Anti-LRP4 antibody assay", "CT chest with contrast for thymoma", "Serum anti-striational muscle antibody testing"], "answer": "E", "answer_index": 4, "explanation": "This presentation represents immune checkpoint inhibitor-induced myasthenia gravis, which is strongly associated with anti-striational muscle antibodies (particularly anti-titin) in paraneoplastic contexts. While anti-AChR antibodies (A) are positive in most generalized MG, anti-striational antibodies have higher specificity for thymoma-associated and paraneoplastic MG in cancer patients on immunotherapy. Anti-MuSK (B) and anti-LRP4 (C) antibodies are associated with different MG subtypes but not specifically with paraneoplastic forms. CT for thymoma (D) is indicated but not the most specific test for pathophysiology. The combination of immune checkpoint therapy with these neurological findings makes anti-striational antibodies the key diagnostic marker.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (miskeyed)\\nVerdict on keyed answer: Miskeyed – best answer is A, not E.\\n\\nKey stem clues: 62-year-old man with metastatic RCC on nivolumab/ipilimumab; subacute diplopia, fatigable ptosis, dysphagia, proximal weakness, normal pupils; decremental response on low-frequency repetitive nerve stimulation. This is classic generalized myasthenia gravis, likely immune checkpoint inhibitor–associated.\\n\\nMost specific diagnostic test for the *underlying pathophysiology* of MG is serum anti–acetylcholine receptor (AChR) antibody testing. Anti-AChR antibodies directly reflect the pathogenic mechanism at the neuromuscular junction and are the standard, specific diagnostic marker in generalized MG. Anti-striational antibodies (E) are less specific: they are paraneoplastic/thymoma-associated markers, not the primary pathophysiologic antibody and are not required or specific to ICI-induced MG.\\n\\nOther options: Anti-MuSK (B) and anti-LRP4 (C) are for seronegative/non–AChR MG subsets and less applicable here; CT chest (D) evaluates thymoma but is not a diagnostic *pathophysiology* test.\\n\\nMain medical accuracy issue: the explanation overstates specificity of anti-striational antibodies for ICI-induced/paraneoplastic MG relative to anti-AChR. \\n\\nMinimal fix: Change the key and explanation to make A (anti-AChR antibody titer) the correct answer and adjust rationale accordingly.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (miskeyed)\nVerdict on keyed answer: Miskeyed – best answer is A, not E.\n\nKey stem clues: 62-year-old man with metastatic RCC on nivolumab/ipilimumab; subacute diplopia, fatigable ptosis, dysphagia, proximal weakness, normal pupils; decremental response on low-frequency repetitive nerve stimulation. This is classic generalized myasthenia gravis, likely immune checkpoint inhibitor–associated.\n\nMost specific diagnostic test for the *underlying pathophysiology* of MG is serum anti–acetylcholine receptor (AChR) antibody testing. Anti-AChR antibodies directly reflect the pathogenic mechanism at the neuromuscular junction and are the standard, specific diagnostic marker in generalized MG. Anti-striational antibodies (E) are less specific: they are paraneoplastic/thymoma-associated markers, not the primary pathophysiologic antibody and are not required or specific to ICI-induced MG.\n\nOther options: Anti-MuSK (B) and anti-LRP4 (C) are for seronegative/non–AChR MG subsets and less applicable here; CT chest (D) evaluates thymoma but is not a diagnostic *pathophysiology* test.\n\nMain medical accuracy issue: the explanation overstates specificity of anti-striational antibodies for ICI-induced/paraneoplastic MG relative to anti-AChR. \n\nMinimal fix: Change the key and explanation to make A (anti-AChR antibody titer) the correct answer and adjust rationale accordingly.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-003", "question": "A 34-year-old pregnant woman at 32 weeks gestation presents with acute-onset severe headache, photophobia, and confusion. BP is 150/95 mmHg. MRI brain shows bilateral cortical and subcortical edema predominantly in posterior parietal and occipital lobes, with patchy cortical diffusion restriction. MR venography is normal. She has no proteinuria. Which of the following is the most likely underlying vascular pathophysiology?", "options": ["Cerebral venous sinus thrombosis", "Posterior reversible encephalopathy syndrome", "Reversible cerebral vasoconstriction syndrome", "Eclampsia without hypertension", "Posterior circulation ischemic stroke"], "answer": "C", "answer_index": 2, "explanation": "This represents reversible cerebral vasoconstriction syndrome (RCVS) in pregnancy, characterized by thunderclap headache, normal venography, and posterior-predominant edema with diffusion restriction. The key distinction from PRES (B) is the presence of cortical diffusion restriction and more severe headache. RCVS involves segmental cerebral arterial vasoconstriction rather than hypertensive breakthrough autoregulation. Cerebral venous thrombosis (A) would show venous occlusion. Eclampsia (D) typically requires significant hypertension and proteinuria. Posterior circulation stroke (E) would show more defined arterial territory infarction rather than patchy cortical involvement.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: U (underspecified, tending toward M)\\nVerdict on keyed answer: Not uniquely determinable; key likely misassigned but item mainly underspecified.\\n\\nKey stem clues: 34-year-old at 32 weeks, acute severe headache, photophobia, confusion; BP 150/95 (mildly elevated), MRI with bilateral cortical/subcortical edema, posterior parietal/occipital predominance, patchy cortical diffusion restriction; normal MRV; no proteinuria. Question asks for vascular pathophysiology but answer list mixes diagnoses and mechanisms.\\n\\nMain logical issues: The stem asks for “underlying vascular pathophysiology,” yet options B, C, D, E are clinical syndromes, while A is a mechanism/etiology. PRES (B) and RCVS (C) are both plausible. PRES classically in pregnancy/posterior edema, but usually without diffusion restriction; RCVS classically thunderclap headache + angiographic segmental vasoconstriction, which is not provided. The explanation asserts RCVS based on “thunderclap” and arterial vasoconstriction, neither documented in the stem (no thunderclap, no angiography). BP is only mildly elevated and absence of proteinuria weakens but does not exclude eclampsia/PRES at 32 weeks. Thus distinguishing PRES vs RCVS requires unprovided details.\\n\\nMedical accuracy: General descriptions of PRES vs RCVS are reasonable, but the claim that cortical diffusion restriction clearly favors RCVS over PRES is debatable; restricted diffusion can occur in severe PRES.\\n\\nMinimal fix: Explicitly describe a thunderclap headache and provide angiographic evidence of segmental arterial narrowing if RCVS is intended, or change stem/imaging to classic PRES and key to B.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (underspecified, tending toward M)\nVerdict on keyed answer: Not uniquely determinable; key likely misassigned but item mainly underspecified.\n\nKey stem clues: 34-year-old at 32 weeks, acute severe headache, photophobia, confusion; BP 150/95 (mildly elevated), MRI with bilateral cortical/subcortical edema, posterior parietal/occipital predominance, patchy cortical diffusion restriction; normal MRV; no proteinuria. Question asks for vascular pathophysiology but answer list mixes diagnoses and mechanisms.\n\nMain logical issues: The stem asks for “underlying vascular pathophysiology,” yet options B, C, D, E are clinical syndromes, while A is a mechanism/etiology. PRES (B) and RCVS (C) are both plausible. PRES classically in pregnancy/posterior edema, but usually without diffusion restriction; RCVS classically thunderclap headache + angiographic segmental vasoconstriction, which is not provided. The explanation asserts RCVS based on “thunderclap” and arterial vasoconstriction, neither documented in the stem (no thunderclap, no angiography). BP is only mildly elevated and absence of proteinuria weakens but does not exclude eclampsia/PRES at 32 weeks. Thus distinguishing PRES vs RCVS requires unprovided details.\n\nMedical accuracy: General descriptions of PRES vs RCVS are reasonable, but the claim that cortical diffusion restriction clearly favors RCVS over PRES is debatable; restricted diffusion can occur in severe PRES.\n\nMinimal fix: Explicitly describe a thunderclap headache and provide angiographic evidence of segmental arterial narrowing if RCVS is intended, or change stem/imaging to classic PRES and key to B.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-004", "question": "A 57-year-old man with alcoholic cirrhosis (Child-Pugh B) presents with fever, abdominal pain, and altered mental status. Paracentesis reveals ascitic fluid with 450 neutrophils/mm³. Blood and ascitic fluid cultures grow extended-spectrum beta-lactamase (ESBL) producing Escherichia coli. He receives meropenem for 72 hours but remains febrile with worsening encephalopathy. Repeat paracentesis shows 520 neutrophils/mm³ with negative cultures. Which of the following is the most appropriate next step?", "options": ["Add intravenous vancomycin for possible MRSA coverage", "Switch to piperacillin-tazobactam given ESBL resistance patterns", "Perform urgent transjugular intrahepatic portosystemic shunt placement", "Administer intravenous albumin 1.5 g/kg on day 1 and 1.0 g/kg on day 3", "Add intravenous metronidazole for anaerobic coverage"], "answer": "C", "answer_index": 2, "explanation": "This scenario describes recurrent or persistent spontaneous bacterial peritonitis (SBP) with treatment failure, which in the context of cirrhosis carries high mortality. TIPS placement reduces portal pressure and may improve outcomes in refractory SBP by decreasing bacterial translocation. Albumin (D) is indicated for SBP but already should have been given initially. Antibiotic changes (A, B, E) are inappropriate with negative repeat cultures and clinical deterioration despite appropriate initial therapy. In refractory SBP with ongoing inflammation despite adequate antibiotics, TIPS can be life-saving by addressing the underlying pathophysiology of portal hypertension.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (miskeyed).\\nVerdict on keyed answer: Miskeyed; C is not the best answer.\\n\\nKey stem clues: Alcoholic cirrhosis with SBP (ascitic PMN >250), ESBL E. coli, treated appropriately with meropenem, still febrile with worsening encephalopathy at 72 hours, repeat PMN still elevated and cultures now negative. The central management issue is SBP with high risk for hepatorenal syndrome and mortality.\\n\\nStandard care: For SBP, IV albumin 1.5 g/kg on day 1 and 1.0 g/kg on day 3 is guideline-recommended to prevent hepatorenal syndrome, especially in patients with renal dysfunction or high risk; nothing in the vignette indicates it has already been given. Persistent symptoms at 72 hours warrant reassessment, but TIPS is not standard therapy for refractory SBP and is relatively contraindicated with active infection and worsening encephalopathy. Thus, D is the only evidence-based, clearly appropriate next step among the options.\\n\\nMain medical accuracy issues: The explanation overstates/incorrectly presents TIPS as a treatment for refractory SBP; this conflicts with usual guidelines and ignores TIPS contraindications.\\n\\nMinimal fix: Change the key and explanation to make D the correct answer, and reframe the question explicitly as initial management of SBP (or remove claims about prior albumin).\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (miskeyed).\nVerdict on keyed answer: Miskeyed; C is not the best answer.\n\nKey stem clues: Alcoholic cirrhosis with SBP (ascitic PMN >250), ESBL E. coli, treated appropriately with meropenem, still febrile with worsening encephalopathy at 72 hours, repeat PMN still elevated and cultures now negative. The central management issue is SBP with high risk for hepatorenal syndrome and mortality.\n\nStandard care: For SBP, IV albumin 1.5 g/kg on day 1 and 1.0 g/kg on day 3 is guideline-recommended to prevent hepatorenal syndrome, especially in patients with renal dysfunction or high risk; nothing in the vignette indicates it has already been given. Persistent symptoms at 72 hours warrant reassessment, but TIPS is not standard therapy for refractory SBP and is relatively contraindicated with active infection and worsening encephalopathy. Thus, D is the only evidence-based, clearly appropriate next step among the options.\n\nMain medical accuracy issues: The explanation overstates/incorrectly presents TIPS as a treatment for refractory SBP; this conflicts with usual guidelines and ignores TIPS contraindications.\n\nMinimal fix: Change the key and explanation to make D the correct answer, and reframe the question explicitly as initial management of SBP (or remove claims about prior albumin).", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-005", "question": "A 41-year-old woman with antiphospholipid syndrome (triple positive) on warfarin (INR 2.8) presents with acute right hemiparesis and aphasia. CT angiogram shows complete occlusion of the left middle cerebral artery M1 segment. She is 4 hours from symptom onset. Which of the following is the most appropriate acute intervention?", "options": ["Administer intravenous tissue plasminogen activator", "Proceed with mechanical thrombectomy without thrombolysis", "Give intravenous heparin bolus followed by infusion", "Administer intra-arterial thrombolysis via catheter", "Continue warfarin and add aspirin 325 mg"], "answer": "B", "answer_index": 1, "explanation": "In antiphospholipid syndrome with acute large vessel occlusion, mechanical thrombectomy is indicated regardless of anticoagulation status. tPA (A) is contraindicated with therapeutic INR >1.7. Heparin (C) adds bleeding risk without proven benefit in acute stroke with therapeutic anticoagulation. Intra-arterial thrombolysis (D) carries similar bleeding risks as IV tPA. Continuing warfarin with aspirin (E) does not address acute occlusion. Mechanical thrombectomy has shown benefit up to 24 hours in selected patients and is not contraindicated by therapeutic anticoagulation if the procedure can be performed safely.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 41-year-old woman, triple-positive antiphospholipid syndrome on warfarin with therapeutic INR 2.8, acute right hemiparesis and aphasia, CT angiogram showing complete left M1 MCA occlusion, 4 hours from onset. This is an acute ischemic stroke due to a large-vessel occlusion in an anticoagulated patient. IV tPA (A) is contraindicated when INR >1.7, consistent with AHA/ASA guidelines. Mechanical thrombectomy (B) is indicated for proximal large-vessel occlusion within 6 hours (and up to 24 in selected patients) and is not contraindicated by therapeutic warfarin. Heparin infusion (C) has no established role in acute ischemic stroke and increases bleeding risk. Intra-arterial thrombolysis (D) has largely been supplanted by mechanical thrombectomy and still has similar hemorrhagic risk as IV tPA in the setting of therapeutic anticoagulation. Continuing warfarin and adding aspirin (E) fails to reperfuse the occluded vessel.\\nMain medical accuracy issues: Minor—wording about “regardless of anticoagulation status” could be nuanced to “therapeutic warfarin is not a contraindication.”\\nMinimal fix: Clarify in the explanation (not stem) that therapeutic warfarin does not contraindicate mechanical thrombectomy and specify tPA contraindication due to INR >1.7 per guidelines.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 41-year-old woman, triple-positive antiphospholipid syndrome on warfarin with therapeutic INR 2.8, acute right hemiparesis and aphasia, CT angiogram showing complete left M1 MCA occlusion, 4 hours from onset. This is an acute ischemic stroke due to a large-vessel occlusion in an anticoagulated patient. IV tPA (A) is contraindicated when INR >1.7, consistent with AHA/ASA guidelines. Mechanical thrombectomy (B) is indicated for proximal large-vessel occlusion within 6 hours (and up to 24 in selected patients) and is not contraindicated by therapeutic warfarin. Heparin infusion (C) has no established role in acute ischemic stroke and increases bleeding risk. Intra-arterial thrombolysis (D) has largely been supplanted by mechanical thrombectomy and still has similar hemorrhagic risk as IV tPA in the setting of therapeutic anticoagulation. Continuing warfarin and adding aspirin (E) fails to reperfuse the occluded vessel.\nMain medical accuracy issues: Minor—wording about “regardless of anticoagulation status” could be nuanced to “therapeutic warfarin is not a contraindication.”\nMinimal fix: Clarify in the explanation (not stem) that therapeutic warfarin does not contraindicate mechanical thrombectomy and specify tPA contraindication due to INR >1.7 per guidelines.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-006", "question": "A 29-year-old woman presents with 6 months of progressive dyspnea and palpitations. Echocardiogram shows severe pulmonary hypertension (RVSP 85 mmHg) with right ventricular dilation but normal left heart function. Right heart catheterization confirms pre-capillary pulmonary hypertension (mPAP 48 mmHg, PAWP 10 mmHg). High-resolution CT shows mosaic attenuation and enlarged central pulmonary arteries. Ventilation-perfusion scan reveals multiple segmental perfusion defects. Which of the following is the definitive diagnostic test?", "options": ["Pulmonary angiogram", "CT pulmonary angiogram", "Genetic testing for BMPR2 mutation", "Lung biopsy", "Exercise right heart catheterization"], "answer": "A", "answer_index": 0, "explanation": "This presentation is classic for chronic thromboembolic pulmonary hypertension (CTEPH). While V/Q scan is the screening test, pulmonary angiography remains the gold standard for defining surgical accessibility and planning pulmonary endarterectomy. CT pulmonary angiography (B) provides anatomical detail but has lower sensitivity for chronic thromboembolic material. Genetic testing (C) is for heritable pulmonary arterial hypertension, not CTEPH. Lung biopsy (D) is contraindicated in severe pulmonary hypertension. Exercise catheterization (E) may confirm exercise-induced PH but doesn't diagnose CTEPH. Pulmonary angiography is essential for determining operability in CTEPH.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: Young woman with pre-capillary pulmonary hypertension (mPAP 48, PAWP 10), mosaic attenuation and enlarged pulmonary arteries on HRCT, and V/Q scan with multiple segmental perfusion defects – classic for chronic thromboembolic pulmonary hypertension (CTEPH). Question asks for the *definitive diagnostic test*.\\n\\nThe correct framework: In suspected CTEPH, V/Q scan is the preferred screening test; conventional pulmonary angiography is considered the reference standard for detailed assessment of chronic thromboembolic lesions and for operability evaluation before pulmonary endarterectomy. Thus, option A (pulmonary angiogram) is the best answer.\\n\\nOption B (CTPA) is increasingly used and very informative but generally regarded as less sensitive for chronic thromboembolic disease and is not yet the formal gold standard. C (BMPR2) applies to idiopathic/heritable PAH, not CTEPH. D (lung biopsy) is contraindicated and unnecessary. E (exercise RHC) is for exercise-induced or occult PH, not diagnosis of CTEPH.\\n\\nMain medical/logical issues: Wording “definitive diagnostic test” could be debated versus V/Q as initial test, but stem has already given a positive V/Q, so angiography as definitive/operative test is defensible.\\n\\nMinimal fix: Rephrase stem to “Which test is the gold standard to definitively characterize disease burden and operability in this condition?”\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: Young woman with pre-capillary pulmonary hypertension (mPAP 48, PAWP 10), mosaic attenuation and enlarged pulmonary arteries on HRCT, and V/Q scan with multiple segmental perfusion defects – classic for chronic thromboembolic pulmonary hypertension (CTEPH). Question asks for the *definitive diagnostic test*.\n\nThe correct framework: In suspected CTEPH, V/Q scan is the preferred screening test; conventional pulmonary angiography is considered the reference standard for detailed assessment of chronic thromboembolic lesions and for operability evaluation before pulmonary endarterectomy. Thus, option A (pulmonary angiogram) is the best answer.\n\nOption B (CTPA) is increasingly used and very informative but generally regarded as less sensitive for chronic thromboembolic disease and is not yet the formal gold standard. C (BMPR2) applies to idiopathic/heritable PAH, not CTEPH. D (lung biopsy) is contraindicated and unnecessary. E (exercise RHC) is for exercise-induced or occult PH, not diagnosis of CTEPH.\n\nMain medical/logical issues: Wording “definitive diagnostic test” could be debated versus V/Q as initial test, but stem has already given a positive V/Q, so angiography as definitive/operative test is defensible.\n\nMinimal fix: Rephrase stem to “Which test is the gold standard to definitively characterize disease burden and operability in this condition?”", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-007", "question": "A 63-year-old man with diabetes and peripheral arterial disease presents with 2 hours of acute, painless monocular vision loss in the right eye. Visual acuity is hand motion only. Funduscopy reveals a pale retina with cherry-red spot and boxcarring of retinal vessels. Carotid duplex shows 90% stenosis of the right internal carotid artery. Which of the following is the most urgent intervention?", "options": ["Intravenous tissue plasminogen activator", "Anterior chamber paracentesis", "Immediate carotid endarterectomy", "Hyperbaric oxygen therapy", "Intra-arterial thrombolysis via ophthalmic artery catheterization"], "answer": "E", "answer_index": 4, "explanation": "This describes central retinal artery occlusion (CRAO) with cherry-red spot and boxcarring, indicating acute ischemia. Intra-arterial thrombolysis via selective ophthalmic artery catheterization within 6-12 hours may restore vision in CRAO, though evidence is limited. IV tPA (A) is not standard for CRAO. Anterior chamber paracentesis (B) is historical but ineffective. Carotid endarterectomy (C) addresses the source but not the acute occlusion. Hyperbaric oxygen (D) has limited evidence. Given the time window and severity, selective intra-arterial thrombolysis offers the best chance for visual recovery in this acute setting.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: U/M (underspecified leading to multiple defensible answers). Verdict on keyed answer: Not uniquely determinable; E is one possible but not clearly best option.\\n\\nKey stem clues: 63-year-old with diabetes, PAD; acute painless monocular vision loss for 2 hours; exam with pale retina, cherry-red spot, boxcarring → classic central retinal artery occlusion (CRAO). Carotid duplex: 90% ipsilateral ICA stenosis, suggesting embolic source and major stroke risk.\\n\\nLogical issues: The question asks for the “most urgent intervention” but does not specify whether the goal is visual recovery vs overall cerebrovascular risk reduction. For CRAO, evidence for intra-arterial thrombolysis (E) is weak and not standard of care; many guidelines emphasize urgent stroke workup and carotid revascularization for high-grade stenosis. Likewise, hyperbaric oxygen (D) is also sometimes used emergently. The vignette does not provide enough context to make intra-arterial thrombolysis clearly the single best urgent choice, so more than one option can be reasonably defended, and the teaching is not guideline-consistent.\\n\\nMedical accuracy: Overstates intra-arterial thrombolysis as preferred/standard for CRAO; current practice is more conservative and variable. \\n\\nMinimal fix: Reframe the question to “Which intervention offers the greatest chance of visual recovery in CRAO within 6 hours?” and update explanation to reflect investigational status, or change key/choices to align with stroke-system management priorities.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U/M (underspecified leading to multiple defensible answers). Verdict on keyed answer: Not uniquely determinable; E is one possible but not clearly best option.\n\nKey stem clues: 63-year-old with diabetes, PAD; acute painless monocular vision loss for 2 hours; exam with pale retina, cherry-red spot, boxcarring → classic central retinal artery occlusion (CRAO). Carotid duplex: 90% ipsilateral ICA stenosis, suggesting embolic source and major stroke risk.\n\nLogical issues: The question asks for the “most urgent intervention” but does not specify whether the goal is visual recovery vs overall cerebrovascular risk reduction. For CRAO, evidence for intra-arterial thrombolysis (E) is weak and not standard of care; many guidelines emphasize urgent stroke workup and carotid revascularization for high-grade stenosis. Likewise, hyperbaric oxygen (D) is also sometimes used emergently. The vignette does not provide enough context to make intra-arterial thrombolysis clearly the single best urgent choice, so more than one option can be reasonably defended, and the teaching is not guideline-consistent.\n\nMedical accuracy: Overstates intra-arterial thrombolysis as preferred/standard for CRAO; current practice is more conservative and variable. \n\nMinimal fix: Reframe the question to “Which intervention offers the greatest chance of visual recovery in CRAO within 6 hours?” and update explanation to reflect investigational status, or change key/choices to align with stroke-system management priorities.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-008", "question": "A 38-year-old woman with history of mitral valve prolapse presents with 3 weeks of daily fevers, night sweats, and new-onset diastolic murmur. Blood cultures are negative after 72 hours. Transthoracic echocardiogram shows a 12mm mobile vegetation on the anterior mitral leaflet with severe mitral regurgitation. Which of the following organisms is most likely responsible?", "options": ["Streptococcus gallolyticus", "Coxiella burnetii", "Bartonella henselae", "Tropheryma whipplei", "Abiotrophia defectiva"], "answer": "C", "answer_index": 2, "explanation": "This presentation suggests culture-negative endocarditis in a patient with pre-existing mitral valve disease. Bartonella henselae is the most common cause of culture-negative endocarditis in patients with valve abnormalities, particularly associated with negative blood cultures, subacute presentation, and large vegetations. Coxiella burnetii (B) typically causes Q fever endocarditis with exposure history. Streptococcus gallolyticus (A) is culture-positive and associated with colorectal pathology. Tropheryma whipplei (D) causes Whipple's disease with systemic symptoms. Abiotrophia (E) is nutritionally variant but usually culture-positive. Bartonella requires serology or PCR for diagnosis and responds to specific antibiotic regimens.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: U (underspecified, leading to multiple defensible answers)\\nVerdict on keyed answer: Not uniquely determinable\\nKey stem clues: 3 weeks of fevers/night sweats (subacute), pre-existing mitral valve prolapse, new murmur with 12 mm vegetation and severe MR, and persistently negative standard blood cultures after 72 hours → culture-negative infective endocarditis on an abnormal valve.\\nMain logical issues: The item asks for the most likely organism causing culture-negative endocarditis. Both Bartonella henselae and Coxiella burnetii are well-recognized major causes of culture-negative endocarditis on abnormal valves. The stem omits exposure history (farm animals/birth products for C. burnetii, cat exposure/homelessness for Bartonella), immunologic phenomena, or serology results that could distinguish them. The explanation’s claim that Bartonella is “most common cause…in patients with valve abnormalities” is not a sufficiently universal or well-established hierarchy to exclude C. burnetii, so more than one option is reasonably defensible.\\nMain medical accuracy issues: Minor overstatement of Bartonella as clearly most common; Abiotrophia can yield difficult/fastidious positives, but not typically persistently negative cultures.\\nMinimal fix: Add a discriminating exposure clue (e.g., cat scratches vs farm animal exposure) or serology result so either Bartonella or Coxiella becomes uniquely correct, and adjust rationale language.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":false,\"logical_false_reason\":\"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (underspecified, leading to multiple defensible answers)\nVerdict on keyed answer: Not uniquely determinable\nKey stem clues: 3 weeks of fevers/night sweats (subacute), pre-existing mitral valve prolapse, new murmur with 12 mm vegetation and severe MR, and persistently negative standard blood cultures after 72 hours → culture-negative infective endocarditis on an abnormal valve.\nMain logical issues: The item asks for the most likely organism causing culture-negative endocarditis. Both Bartonella henselae and Coxiella burnetii are well-recognized major causes of culture-negative endocarditis on abnormal valves. The stem omits exposure history (farm animals/birth products for C. burnetii, cat exposure/homelessness for Bartonella), immunologic phenomena, or serology results that could distinguish them. The explanation’s claim that Bartonella is “most common cause…in patients with valve abnormalities” is not a sufficiently universal or well-established hierarchy to exclude C. burnetii, so more than one option is reasonably defensible.\nMain medical accuracy issues: Minor overstatement of Bartonella as clearly most common; Abiotrophia can yield difficult/fastidious positives, but not typically persistently negative cultures.\nMinimal fix: Add a discriminating exposure clue (e.g., cat scratches vs farm animal exposure) or serology result so either Bartonella or Coxiella becomes uniquely correct, and adjust rationale language.\n", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-009", "question": "A 52-year-old woman with rheumatoid arthritis on methotrexate presents with progressive dyspnea and dry cough. High-resolution CT shows extensive ground-glass opacities with centrilobular nodules and tree-in-bud pattern predominantly in upper lobes. Bronchoscopy with transbronchial biopsy reveals non-necrotizing granulomas with multinucleated giant cells. Which of the following is the most likely diagnosis?", "options": ["Methotrexate pneumonitis", "Rheumatoid arthritis-associated interstitial lung disease", "Mycobacterium avium complex infection", "Sarcoidosis", "Hypersensitivity pneumonitis"], "answer": "C", "answer_index": 2, "explanation": "The combination of upper lobe predominance, tree-in-bud pattern, and non-necrotizing granulomas in an immunocompromised patient on methotrexate is classic for nontuberculous mycobacterial infection, particularly MAC. Methotrexate pneumonitis (A) typically shows diffuse alveolar damage pattern. RA-ILD (B) usually shows UIP or NSIP patterns. Sarcoidosis (D) shows perilymphatic nodules and hilar adenopathy. Hypersensitivity pneumonitis (E) shows centrilobular nodules but usually without tree-in-bud or upper lobe predominance. Immunosuppressed patients on methotrexate are at increased risk for NTM infections, which can mimic granulomatous diseases.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 52-year-old woman with RA on methotrexate (immunosuppressed); progressive dyspnea and dry cough; HRCT with extensive ground-glass opacities, centrilobular nodules, and tree-in-bud pattern with upper lobe predominance; transbronchial biopsy showing non-necrotizing granulomas with multinucleated giant cells. In an immunocompromised host, upper-lobe centrilobular nodules plus tree-in-bud strongly suggest endobronchial spread of infection; non-necrotizing granulomas are compatible with nontuberculous mycobacterial (NTM) infection such as MAC.\\nAlternative choices: Methotrexate pneumonitis more typically shows diffuse interstitial or organizing pneumonia patterns, not tree-in-bud or nodular endobronchial spread. RA-associated ILD is usually UIP/NSIP and not primarily granulomatous or tree-in-bud. Sarcoidosis classically has perilymphatic nodules and bilateral hilar/mediastinal adenopathy rather than tree-in-bud bronchiolitis. Hypersensitivity pneumonitis can have centrilobular nodules and granulomas but tree-in-bud and specific NTM risk with methotrexate make MAC more characteristic.\\nMain medical accuracy issues: Minor—HP can show tree-in-bud in subacute/chronic forms; description “usually without” is somewhat oversimplified but does not undermine the best answer.\\nMinimal fix: Add explicit mention of negative hilar adenopathy or bronchoalveolar lavage growing NTM to further distinguish from sarcoidosis/HP.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 52-year-old woman with RA on methotrexate (immunosuppressed); progressive dyspnea and dry cough; HRCT with extensive ground-glass opacities, centrilobular nodules, and tree-in-bud pattern with upper lobe predominance; transbronchial biopsy showing non-necrotizing granulomas with multinucleated giant cells. In an immunocompromised host, upper-lobe centrilobular nodules plus tree-in-bud strongly suggest endobronchial spread of infection; non-necrotizing granulomas are compatible with nontuberculous mycobacterial (NTM) infection such as MAC.\nAlternative choices: Methotrexate pneumonitis more typically shows diffuse interstitial or organizing pneumonia patterns, not tree-in-bud or nodular endobronchial spread. RA-associated ILD is usually UIP/NSIP and not primarily granulomatous or tree-in-bud. Sarcoidosis classically has perilymphatic nodules and bilateral hilar/mediastinal adenopathy rather than tree-in-bud bronchiolitis. Hypersensitivity pneumonitis can have centrilobular nodules and granulomas but tree-in-bud and specific NTM risk with methotrexate make MAC more characteristic.\nMain medical accuracy issues: Minor—HP can show tree-in-bud in subacute/chronic forms; description “usually without” is somewhat oversimplified but does not undermine the best answer.\nMinimal fix: Add explicit mention of negative hilar adenopathy or bronchoalveolar lavage growing NTM to further distinguish from sarcoidosis/HP.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "question_id": "20251205T082731900Z_deepseek-v3.2_seed124-010", "question": "A 44-year-old woman presents with 8 months of progressive proximal muscle weakness, heliotrope rash, and Gottron's papules. Muscle biopsy shows perfascicular atrophy and MAC deposition on capillaries. She tests positive for anti-MDA5 antibodies. Which of the following complications carries the highest immediate mortality risk?", "options": ["Aspiration pneumonia", "Cardiac conduction abnormalities", "Rapidly progressive interstitial lung disease", "Malignancy-associated deterioration", "Calcinosis universalis"], "answer": "C", "answer_index": 2, "explanation": "Anti-MDA5 antibody-positive dermatomyositis is strongly associated with rapidly progressive interstitial lung disease (RP-ILD), which has mortality exceeding 50% within 6 months despite treatment. This subtype shows characteristic skin findings but often minimal muscle involvement, with MAC deposition on capillaries. While aspiration (A) and cardiac issues (B) occur in myositis, RP-ILD is the most lethal complication in anti-MDA5 patients. Malignancy risk (D) is lower with anti-MDA5 than with anti-TIF1γ. Calcinosis (E) is chronic but not immediately life-threatening. Early recognition and aggressive immunosuppression for RP-ILD are critical in anti-MDA5 dermatomyositis.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Adult woman with classic dermatomyositis rash (heliotrope, Gottron’s), biopsy showing perifascicular atrophy and MAC deposition, and specifically positive anti-MDA5 antibodies. Question asks for the complication with the highest immediate mortality risk. Anti-MDA5 dermatomyositis is well known to be strongly associated with rapidly progressive interstitial lung disease (RP-ILD) with very high short-term mortality (often >50% within months), far exceeding typical short‑term risk from aspiration events, usual cardiac conduction abnormalities, malignancy course, or calcinosis.\\nOther options: Aspiration pneumonia (A) is a recognized complication of myositis but generally treatable and not uniquely linked to anti-MDA5 with such extreme early mortality. Cardiac conduction abnormalities (B) occur in inflammatory myopathies but are less frequent and usually not as acutely lethal as RP-ILD in this antibody subset. Malignancy-associated deterioration (D) is less strongly associated with anti-MDA5 than other antibodies and usually has a more prolonged course. Calcinosis universalis (E) is morbid but chronic, not an immediate mortality threat.\\nMain medical/logical issues: None significant; associations and relative risks are accurate.\\nMinimal fix: Add “in anti-MDA5–positive dermatomyositis” to the stem to anchor the context explicitly to that subtype, but this is already clear.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Adult woman with classic dermatomyositis rash (heliotrope, Gottron’s), biopsy showing perifascicular atrophy and MAC deposition, and specifically positive anti-MDA5 antibodies. Question asks for the complication with the highest immediate mortality risk. Anti-MDA5 dermatomyositis is well known to be strongly associated with rapidly progressive interstitial lung disease (RP-ILD) with very high short-term mortality (often >50% within months), far exceeding typical short‑term risk from aspiration events, usual cardiac conduction abnormalities, malignancy course, or calcinosis.\nOther options: Aspiration pneumonia (A) is a recognized complication of myositis but generally treatable and not uniquely linked to anti-MDA5 with such extreme early mortality. Cardiac conduction abnormalities (B) occur in inflammatory myopathies but are less frequent and usually not as acutely lethal as RP-ILD in this antibody subset. Malignancy-associated deterioration (D) is less strongly associated with anti-MDA5 than other antibodies and usually has a more prolonged course. Calcinosis universalis (E) is morbid but chronic, not an immediate mortality threat.\nMain medical/logical issues: None significant; associations and relative risks are accurate.\nMinimal fix: Add “in anti-MDA5–positive dermatomyositis” to the stem to anchor the context explicitly to that subtype, but this is already clear.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]